Somewhat Positive Media Coverage Somewhat Unlikely to Affect Metabolix (YTEN) Share Price

Press coverage about Metabolix (NASDAQ:YTEN) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Metabolix earned a news impact score of 0.19 on Accern’s scale. Accern also assigned press coverage about the specialty chemicals company an impact score of 45.6742866962718 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Metabolix (YTEN) traded down 1.82% on Friday, hitting $3.23. The stock had a trading volume of 6,141 shares. The company’s 50 day moving average is $2.95 and its 200 day moving average is $2.48. Metabolix has a 12-month low of $0.25 and a 12-month high of $9.03. The firm has a market cap of $11.16 million, a PE ratio of 13.46 and a beta of 3.63.

Metabolix (NASDAQ:YTEN) last announced its earnings results on Thursday, August 10th. The specialty chemicals company reported ($0.96) earnings per share (EPS) for the quarter. Metabolix had a negative return on equity of 145.04% and a negative net margin of 190.57%. The business had revenue of $0.29 million for the quarter.

TRADEMARK VIOLATION WARNING: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://ledgergazette.com/2017/10/08/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-metabolix-yten-share-price.html.

Metabolix Company Profile

Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.

Insider Buying and Selling by Quarter for Metabolix (NASDAQ:YTEN)

Receive News & Ratings for Metabolix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metabolix Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply